Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-11-07
1986-04-22
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
568328, 2602393T, A61K 3155, C07D22332
Patent
active
045842949
ABSTRACT:
The invention relates to fused tricyclic lactams and related compounds which are useful as angiotensin converting enzyme inhibitors and as antihypertensives.
REFERENCES:
patent: 4410520 (1983-10-01), Watthey
patent: 4415496 (1983-11-01), Harris et al.
Bond Robert T.
Merck & Co. , Inc.
Mitri Salvatore C.
Sudol Michael C.
LandOfFree
Fused tricyclic lactams as angiotensin converting enzyme inhibit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused tricyclic lactams as angiotensin converting enzyme inhibit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused tricyclic lactams as angiotensin converting enzyme inhibit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1915570